Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Parasitic Diseases

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 24 articles: HTML format

Single Articles

May 2023
1. CHU CS, Stolbrink M, Stolady D, Saito M, et al
   Severe falciparum and vivax malaria on the Thailand-Myanmar border: A review of 1503 cases.
   Clin Infect Dis. 2023 May 5:ciad262. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2023
2. LYRA MR, Oliveira LFA, Schubach AO, Sampaio RN, et al
   A randomized, controlled, non-inferiority, multicenter trial of systemic versus intralesional treatment with meglumine antimoniate for cutaneous leishmaniasis in Brazil.
   Clin Infect Dis. 2023 Apr 26:ciad253. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. ARONSON NE, Billick K
   Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns.
   Clin Infect Dis. 2023 Apr 26:ciad248. doi: 10.1093.
   PubMed    
   
   
   February 2023
4. BARBER BE, Abd-Rahman AN, Webster R, Potter AJ, et al
   Characterizing the blood stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
   Clin Infect Dis. 2023 Feb 16:ciad075. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. WHITE NJ
   The antimalarial activity of tafenoquine in falciparum malaria.
   Clin Infect Dis. 2023 Feb 16:ciad079. doi: 10.1093.
   PubMed    
   
   
   
6. BLANKEN SL, Soumare HDM, Andolina C, Lanke K, et al
   How to Interpret Parasite Persistence and Transmission to Mosquitoes After Antimalarial Treatment in Kenya?
   Clin Infect Dis. 2023;76:555-557.
   PubMed    
   
   
   December 2022
7. FUKUDA N, Balikagala B, Ueno T, Anywar DA, et al
   The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa.
   Clin Infect Dis. 2022 Dec 15:ciac944. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2022
8. MUSA AM, Mbui J, Mohammed R, Olobo J, et al
   Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
   Clin Infect Dis. 2022 Sep 27. pii: 6718130. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2022
9. WEBSTER R, Mitchell H, Peters JM, Heunis J, et al
   Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
   Clin Infect Dis. 2022 Jun 22. pii: 6613332. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2022
10. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Correction to: Fine-scale Spatiotemporal Mapping of Asymptomatic and Clinical Plasmodium falciparum Infections: Epidemiological Evidence for Targeted Malaria Elimination Interventions.
    Clin Infect Dis. 2022 Apr 26. pii: 6574503. doi: 10.1093.
    PubMed    
    
    
    
11. IPPOLITO MM, Kabuya JB, Hauser M, Kamavu LK, et al
    Whole blood transfusion for severe malarial anemia in a high Plasmodium falciparum transmission setting.
    Clin Infect Dis. 2022 Apr 19. pii: 6570805. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. CARVALHO AM, Viana SM, Andrade BB, Oliveira F, et al
    Immune response to LinB13, a Lutzomyia intermedia salivary protein correlates with disease severity in tegumentary leishmaniasis.
    Clin Infect Dis. 2022 Apr 6. pii: 6564311. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2022
13. BURZA S, Mahajan R, Kazmi S, Alexander N, et al
    AmBisome monotherapy and combination AmBisome - miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: a randomised open label, parallel arm, phase 3 trial.
    Clin Infect Dis. 2022 Feb 11. pii: 6527047. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
14. MOHANTY S, Sahu PK, Pattnaik R, Majhi M, et al
    Evidence of Brain Alterations in Noncerebral Falciparum Malaria.
    Clin Infect Dis. 2021 Dec 15. pii: 6460593. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
15. OUATTARA M, Bassa FK, Diakite NR, Hattendorf J, et al
    Effectiveness of Four Different Interventions against Schistosoma haematobium in a Seasonal Transmission Setting of Cote d'Ivoire: A Cluster Randomized Trial.
    Clin Infect Dis. 2021 Sep 14. pii: 6369964. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
16. SCHMITT EK, Ndayisaba G, Yeka A, Asante KP, et al
    Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria.
    Clin Infect Dis. 2021 Aug 19. pii: 6354946. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. CLARK J, Arinaitwe M, Nankasi A, Faust CL, et al
    Reconciling egg- and antigen-based estimates of Schistosoma mansoni clearance and reinfection: a modelling study.
    Clin Infect Dis. 2021 Aug 6. pii: 6343396. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
18. FAN H, Gai W, Zhang L, Ma Y, et al
    Parasite Circulating Cell-free DNA in the Blood of Alveolar Echinococcosis Patients as a Diagnostic and Treatment-Status Indicator.
    Clin Infect Dis. 2021;73:e246-e251.
    PubMed     Abstract available
    
    
    May 2021
19. KAMRAN M, Ejazi SA, Choudhury ST, Bhattacharyya A, et al
    A novel antigen, otubain cysteine peptidase of Leishmania donovani improves serodiagnosis of visceral leishmaniasis and monitors treatment response.
    Clin Infect Dis. 2021 May 13. pii: 6275590. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2021
20. AYABINA D, Kura K, Toor J, Graham M, et al
    Maintaining low prevalence of Schistosoma mansoni: modelling the effect of less frequent treatment.
    Clin Infect Dis. 2021 Apr 28. pii: 6256990. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. COFFENG LE, Le Rutte EA, Munoz J, Adams E, et al
    Antibody and antigen prevalence as indicators of ongoing transmission or elimination of visceral leishmaniasis: a modelling study.
    Clin Infect Dis. 2021 Apr 27. pii: 6255961. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. COFFENG LE, Levecke B, Hattendorf J, Walker M, et al
    Survey design to monitor drug efficacy for the control of soil-transmitted helminthiasis and schistosomiasis.
    Clin Infect Dis. 2021 Apr 27. pii: 6255959. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. SUMNER KM, Freedman E, Mangeni JN, Obala AA, et al
    Exposure to diverse Plasmodium falciparum genotypes shapes the risk of symptomatic malaria in incident and persistent infections: A longitudinal molecular epidemiologic study in Kenya.
    Clin Infect Dis. 2021 Apr 27. pii: 6255633. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2019
24. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parasitic Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: